You Can Still Get Your Mail Order Abortion Pills (For Now)
SCOTUS has temporarily blocked the Fifth Circuit's temporary block of the FDA's policy on abortion medication prescription rules.
TL;DR
- The Fifth Circuit Court temporarily banned the mailing of mifepristone, challenging a 2023 FDA policy that allowed mail-order prescriptions.
- The Supreme Court has temporarily blocked this ban, allowing continued access to mifepristone through pharmacies and mail.
- The ruling is on hold until May 11 to allow the Supreme Court to further consider the issue.
- Louisiana argues the FDA policy undermines its state abortion ban.
- Mifepristone has been used safely in the U.S. for 25 years and is used for various medical purposes beyond abortion.
- The article argues there is no health-related reason to require in-person visits for mifepristone, and the restrictions are meant to reduce access.
- The FDA's role is to create policies based on safety and efficacy, not on political or religious beliefs.
- The article speculates that a ruling against mifepristone access could negatively impact Republicans in future elections.